Literature DB >> 23620135

Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis.

Meiyi Li1, Tao Zeng, Rui Liu, Luonan Chen.   

Abstract

Identifying early warning signals of critical transitions during disease progression is a key to achieving early diagnosis of complex diseases. By exploiting rich information of high-throughput data, a novel model-free method has been developed to detect early warning signals of diseases. Its theoretical foundation is based on dynamical network biomarker (DNB), which is also called as the driver (or leading) network of the disease because components or molecules in DNB actually drive the whole system from one state (e.g. normal state) to another (e.g. disease state). In this article, we first reviewed the concept and main results of DNB theory, and then applied the new method to the analysis of type 2 diabetes mellitus (T2DM). Specifically, based on the temporal-spatial gene expression data of T2DM, we identified tissue-specific DNBs corresponding to the critical transitions occurring in liver, adipose and muscle during T2DM development and progression. Actually, we found that there are two different critical states during T2DM development characterized as responses to insulin resistance and serious inflammation, respectively. Interestingly, a new T2DM-associated function, i.e. steroid hormone biosynthesis, was discovered, and those related genes were significantly dysregulated in liver and adipose at the first critical transition during T2DM deterioration. Moreover, the dysfunction of genes related to responding hormone was also detected in muscle at the similar period. Based on the functional and network analysis on pathogenic molecular mechanism of T2DM, we showed that most of DNB genes, in particular the core ones, tended to be located at the upstream of biological pathways, which implied that DNB genes act as the causal factors rather than the consequence to drive the downstream molecules to change their transcriptional activities. This also validated our theoretical prediction of DNB as the driver network. As shown in this study, DNB can not only signal the emergence of the critical transitions for early diagnosis of diseases, but can also provide the causal network of the transitions for revealing molecular mechanisms of disease initiation and progression at a network level.

Entities:  

Keywords:  Type-2 diabetes; critical transition; disease progression; dynamical network biomarker (DNB); leading network; multi-tissues

Mesh:

Substances:

Year:  2013        PMID: 23620135     DOI: 10.1093/bib/bbt027

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  33 in total

1.  "Dysfunctions" induced by Roux-en-Y gastric bypass surgery are concomitant with metabolic improvement independent of weight loss.

Authors:  Meiyi Li; Zhiyuan Liu; Bangguo Qian; Weixin Liu; Katsuhisa Horimoto; Jie Xia; Meilong Shi; Bing Wang; Huarong Zhou; Luonan Chen
Journal:  Cell Discov       Date:  2020-01-28       Impact factor: 10.849

Review 2.  Network Control Models With Personalized Genomics Data for Understanding Tumor Heterogeneity in Cancer.

Authors:  Jipeng Yan; Zhuo Hu; Zong-Wei Li; Shiren Sun; Wei-Feng Guo
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

3.  Synchrony of biomarker variability indicates a critical transition: Application to mortality prediction in hemodialysis.

Authors:  Alan A Cohen; Diana L Leung; Véronique Legault; Dominique Gravel; F Guillaume Blanchet; Anne-Marie Côté; Tamàs Fülöp; Juhong Lee; Frédérik Dufour; Mingxin Liu; Yuichi Nakazato
Journal:  iScience       Date:  2022-05-10

4.  Detecting the tipping points in a three-state model of complex diseases by temporal differential networks.

Authors:  Pei Chen; Yongjun Li; Xiaoping Liu; Rui Liu; Luonan Chen
Journal:  J Transl Med       Date:  2017-10-26       Impact factor: 5.531

Review 5.  Data analysis methods for defining biomarkers from omics data.

Authors:  Chao Li; Zhenbo Gao; Benzhe Su; Guowang Xu; Xiaohui Lin
Journal:  Anal Bioanal Chem       Date:  2021-12-24       Impact factor: 4.142

6.  Big biological data: challenges and opportunities.

Authors:  Yixue Li; Luonan Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-10-14       Impact factor: 7.691

Review 7.  Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers.

Authors:  Hao Chen; Zhitu Zhu; Yichun Zhu; Jian Wang; Yunqing Mei; Yunfeng Cheng
Journal:  J Cell Mol Med       Date:  2015-01-05       Impact factor: 5.310

8.  Identifying critical differentiation state of MCF-7 cells for breast cancer by dynamical network biomarkers.

Authors:  Pei Chen; Rui Liu; Luonan Chen; Kazuyuki Aihara
Journal:  Front Genet       Date:  2015-07-28       Impact factor: 4.599

Review 9.  Network biomarkers, interaction networks and dynamical network biomarkers in respiratory diseases.

Authors:  Xiaodan Wu; Luonan Chen; Xiangdong Wang
Journal:  Clin Transl Med       Date:  2014-06-24

10.  Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence.

Authors:  Jinling Yan; Peiluan Li; Rong Gao; Ying Li; Luonan Chen
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.